Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,600 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The lower limit of intensity to control uremia during continuous renal replacement therapy.
Yasuda H, Uchino S, Uji M, Ohnuma T, Namba Y, Katayama S, Kawarazaki H, Toki N, Takeda K, Izawa J, Tokuhira N, Nagata I; Japanese Society for Physicians and Trainees in Intensive Care Clinical Trial Group. Yasuda H, et al. Among authors: takeda k. Crit Care. 2014 Oct 7;18(5):539. doi: 10.1186/s13054-014-0539-4. Crit Care. 2014. PMID: 25672828 Free PMC article.
Factors predicting successful discontinuation of continuous renal replacement therapy.
Katayama S, Uchino S, Uji M, Ohnuma T, Namba Y, Kawarazaki H, Toki N, Takeda K, Yasuda H, Izawa J, Tokuhira N, Nagata I; Japanese Society of Education for Physicians and Trainees in Intensive Care (JSEPTIC) Clinical Trial Group. Katayama S, et al. Among authors: takeda k. Anaesth Intensive Care. 2016 Jul;44(4):453-7. doi: 10.1177/0310057X1604400401. Anaesth Intensive Care. 2016. PMID: 27456174
Validity of low-intensity continuous renal replacement therapy*.
Uchino S, Toki N, Takeda K, Ohnuma T, Namba Y, Katayama S, Kawarazaki H, Yasuda H, Izawa J, Uji M, Tokuhira N, Nagata I; Japanese Society for Physicians and Trainees in Intensive Care (JSEPTIC) Clinical Trial Group. Uchino S, et al. Among authors: takeda k. Crit Care Med. 2013 Nov;41(11):2584-91. doi: 10.1097/CCM.0b013e318298622e. Crit Care Med. 2013. PMID: 23939357
Sepsis may not be a risk factor for mortality in patients with acute kidney injury treated with continuous renal replacement therapy.
Nagata I, Uchino S, Tokuhira N, Ohnuma T, Namba Y, Katayama S, Kawarazaki H, Toki N, Takeda K, Yasuda H, Izawa J, Uji M; JSEPTIC (Japanese Society for Physicians Trainees in Intensive Care) Clinical Trial Group. Nagata I, et al. Among authors: takeda k. J Crit Care. 2015 Oct;30(5):998-1002. doi: 10.1016/j.jcrc.2015.06.021. Epub 2015 Jun 26. J Crit Care. 2015. PMID: 26220246
Who may not benefit from continuous renal replacement therapy in acute kidney injury?
Kawarazaki H, Uchino S, Tokuhira N, Ohnuma T, Namba Y, Katayama S, Toki N, Takeda K, Yasuda H, Izawa J, Uji M, Nagata I; JSEPTIC (Japanese Society for Physicians Trainees in Intensive Care) Clinical Trial Group. Kawarazaki H, et al. Among authors: takeda k. Hemodial Int. 2013 Oct;17(4):624-32. doi: 10.1111/hdi.12053. Epub 2013 May 7. Hemodial Int. 2013. PMID: 23651363
External Validation for Acute Kidney Injury Severity Scores: A Multicenter Retrospective Study in 14 Japanese ICUs.
Ohnuma T, Uchino S, Toki N, Takeda K, Namba Y, Katayama S, Kawarazaki H, Yasuda H, Izawa J, Uji M, Tokuhira N, Nagata I; JSEPTIC (Japanese Society for Physicians and Trainees in Intensive Care) Clinical Trial Group. Ohnuma T, et al. Among authors: takeda k. Am J Nephrol. 2015;42(1):57-64. doi: 10.1159/000439118. Am J Nephrol. 2015. PMID: 26337793
Enhanced loading dose of teicoplanin for three days is required to achieve a target trough concentration of 20 μg/mL in patients receiving continuous venovenous haemodiafiltration with a low flow rate.
Ueda T, Takesue Y, Nakajima K, Ichiki K, Ishikawa K, Yamada K, Tsuchida T, Otani N, Ide T, Takeda K, Nishi S, Takahashi Y, Ishihara M, Takubo S, Ikeuchi H, Uchino M, Kimura T. Ueda T, et al. Among authors: takeda k. J Infect Chemother. 2022 Feb;28(2):232-237. doi: 10.1016/j.jiac.2021.10.023. Epub 2021 Nov 27. J Infect Chemother. 2022. PMID: 34844858
Can Grading of Mild Cardiac Allograft Vasculopathy be Further Refined? An angiographic and physiologic assessment of heart transplant recipients with ISHLT CAV 1.
Prasad N, Harris E, Yuzefpolskaya M, DeFilippis EM, Colombo PC, Sayer G, Chernovolenko M, Fried J, Bae D, Oh KT, Raikhelkar J, Topkara VK, Castillo M, Lam EY, Latif F, Takeda K, Uriel N, Einstein AJ, Clerkin KJ. Prasad N, et al. Among authors: takeda k. J Heart Lung Transplant. 2024 Dec 30:S1053-2498(24)02028-X. doi: 10.1016/j.healun.2024.12.013. Online ahead of print. J Heart Lung Transplant. 2024. PMID: 39743049
Immune Stress-induced Tumor Mutation Burden and Neoantigen Expression in 4T1 Mammary Cancer Cells: A Potential Mechanism for Long-term Survival in Patients Treated With Immune Checkpoint Inhibitors.
Ishiguro T, Takeda K, Takayanagi D, Mura E, Suzuki R, Tsurui T, Iriguchi N, Hirasawa Y, Ohkuma R, Shimokawa M, Ariizumi H, Kubota Y, Horiike A, Izumizaki M, Wada S, Yoshimura K, Hoffman RM, Tsunoda T. Ishiguro T, et al. Among authors: takeda k. Cancer Genomics Proteomics. 2025 Jan-Feb;22(1):1-12. doi: 10.21873/cgp.20481. Cancer Genomics Proteomics. 2025. PMID: 39730175
5,600 results